Skip Navigation



QJM Advance Access published online on June 13, 2005
QJM, doi:10.1093/qjmed/hci077
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
98/7/467    most recent
hci077v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hamerman, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hamerman, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

Review

Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies

D. Hamerman 1*

1 From the Department of Medicine and Resnick Gerontology Center, Albert Einstein College of Medicine and Montefiore Medical Center, New York, USA

* To whom correspondence should be addressed.
D. Hamerman, E-mail: hamermandj{at}aol.com


  Abstract

Osteoporosis and atherosclerosis are both widely prevalent in an ageing population, and induce serious morbidities and death. There is growing evidence that in addition to their relationship to ageing, osteoporosis and atherosclerosis are also linked by biological associations. This article reviews their clinical interrelations, discusses the basic biology of bone and the arterial wall, and presents five examples that illustrate their biological linkages. Current therapeutic approaches emerging from these linkages, including statins, bisphosphonates, and the thiazolidinediones, have dual effects on bone and the vasculature. Additional therapies derived from experimental studies that enhance bone density and reduce atherogenesis hold further promise to diminish the morbidity and mortality of osteoporosis and atherosclerosis, with attendant benefits to society.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
R. Sabit, C. E. Bolton, P. H. Edwards, R. J. Pettit, W. D. Evans, C. M. McEniery, I. B. Wilkinson, J. R. Cockcroft, and D. J. Shale
Arterial Stiffness and Osteoporosis in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., June 15, 2007; 175(12): 1259 - 1265.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
J. F. Griffith, D. K. W. Yeung, G. E. Antonio, S. Y. S. Wong, T. C. Y. Kwok, J. Woo, and P. C. Leung
Vertebral Marrow Fat Content and Diffusion and Perfusion Indexes in Women with Varying Bone Density: MR Evaluation
Radiology, December 1, 2006; 241(3): 831 - 838.
[Abstract] [Full Text] [PDF]

Home page
 JBJSHome page
I. McCarthy
The Physiology of Bone Blood Flow: A Review
J. Bone Joint Surg. Am., November 1, 2006; 88(suppl_3): 4 - 9.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.